ARCHIVES

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 1 | January 25, 2008

Download PDF Visit The Full Archive

Related Articles

Ceritinib Demonstrates 58% ORR, 7-month PFS in ALK+ NSCLC

March 28, 2014

Prospects Fading for Funding More CCOPsIn FY ’83; Return to Groups Of Money From Satellites Going To New Programs

July 29, 1983

Letter to the Editor: Expanding the Horizons Of Proton Beam Therapy

August 1, 2014

FDA Working On New Ground Rules For “Adaptive” Clinical Trial Designs.

July 14, 2006

NCI’s International Program Growing, With More Agreements, $8 Million In Contracts And Grants

August 8, 1975

New ACS Structure Proposed, approved

August 6, 1993